Abstract
We previously identified a new bovine immunodeficiency virus (BIV) trans-activator factor of transcription (Tat236) that was derived from a variant of BIV. Here, we report a new BIV long terminal repeat (LTR) sequence (LTRn) that was obtained by PCR from the DNA of cells infected with the BIV variant mentioned above. Sequence analysis indicated that the LTRn U3 region harbors three nucleic acid mutations at residue positions −194, −135 and −114 when compared to the original (wild-type) LTR sequence. Reporter gene assays indicated that LTRn promotes basal and Tat-mediated transactivation activity to levels significantly higher than those obtained with the wild-type LTR. Restoration experiments to the wild-type genotype indicated that both the −135 and −114 nucleic acid substitutions were responsible for the enhanced promoter activity of BIV LTRn.
References
Bassuk AG, Anandappa RT, Leiden JM (1997) Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J Virol 71:3563–3573
Bouillant AM, Ruckerbauer GM, Nielsen KH (1989) Replication of the bovine immunodeficiency-like virus in diploid and aneuploid cells: permanent, latent and virus-productive infections in vitro. Res Virol 140:511–529
Carpenter S, Nadin-Davis SA, Wannemuehler Y, Roth JA (1993) Identification of transactivation-response sequences in the long terminal repeat of bovine immunodeficiency-like virus. J Virol 67:4399–4404
Chirmule N, Pahwa S (1996) Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev 60:386–406
Fong SE, Pallansch LA, Mikovits JA, Lackman-Smith CS, Ruscetti FW, Gonda MA (1995) Cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat. Virology 209:604–614
Fong SE, Greenwood JD, Williamson JC, Derse D, Pallansch LA, Copeland T, Rasmussen L, Mentzer A, Nagashima K, Tobin G, Gonda MA (1997) Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products. Virology 233:339–357
Garvey KJ, Oberste MS, Elser JE, Braun MJ, Gonda MA (1990) Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus. Virology 175:391–409
Gonda MA, Luther DG, Fong SE, Tobin GJ (1994) Bovine immunodeficiency virus: molecular biology and virus-host interactions. Virus Res 32:155–181
Golub EI, Li GG, Volsky DJ (1990) Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J Virol 64:3654–3660
Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98
Hiebenthal-Millow K, Greenough TC, Bretttler DB, Schindler M, Wildum S, Sullivan JL, Kirchhoff F (2003) Alterations in HIV-1 LTR promoter activity during AIDS progression. Virology 317:109–118
Hua J, Caffrey JJ, Cullen BR (1996) Functional consequences of natural sequence variation in the activation domain of HIV-1 Rev. Virology 15:423–429
Krebs FC, Mehrens D, Pomeroy S, Goodenow MM, Wigdahl B (1998) Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. J Biomed Sci 5:31–44
Krebs FC, Hogan TH, Quiterio S, Gartner S, Wigdahl B (2001) Lentiviral LTR-directed expression, sequence variation, and disease Pathogenesis. In: Kuiken C, Foley B, Hahn B, Marx P, McCutchan F, Mellors JW, Wolinsky S, Korber B (eds) HIV Sequence Compendium.. Published by Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, LA-UR 02-2877
Mansky LM (1998) Retrovirus mutation rates and their role in genetic variation. J Gen Virol 79:1337–1345
Martins LP, Chenciner N, Asjo B, Meyerhans A, Wain-Hobson S (1991) Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo. J Virol 65:4502–4507
Maury WR, Thompson J, Jones Q, Bradley S, Denke T, Baccam P, Smazik M, Oaks JL (2005) Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism. J Virol 79:5653–5664
Oberste MS, Greenwood JD, Gonda MA (1991) Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus. J Virol 65:3932–3937
Overbaugh J, Bangham CRM (2001) Selection forces and constraints on retroviral sequence variation. Science 292:1106–1109
Péloponse JMJ Jr, Collette Y, Grégoire C, Bailly C, Campese D, Meurs EF, Olive D, Loret EP (1999) Full peptide synthesis, purification, and characterization of six Tat variants: differences observed between HIV-1 isolates from Africa and other continents. J Biol Chem 274:11473–11478
Serra C, Mameli G, Biolchini A, Ziccheddu M, Curreli S, Arru G, Dolei A (2002) Characterization of an HIV type 1 strain with preferential replication in adherent cells. AIDS Res Hum Retrovir 18:641–647
St-Louis M-C, Cojocariu M, Archambault D (2004) The molecular biology of the bovine immunodeficiency virus: a comparison with other lentiviruses. Animal Health Res Rev 5:125–143
St-Louis M-C, Abed Y, Archambault D (2005) The bovine immunodeficiency virus (BIV): cloning of a tat/rev cDNA encoding a novel Tat protein with enhanced transactivation activity. Arch Virol 150:1529–1547
Valter MM, Hügel A, Su Huang H-J, Cavenee WK, Wiestler OD, Pietsch T, Nicolas W (1999) Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 59:5608–5614
Zhang MJ, Dayton AI (1998) Tolerance of diverse amino acid substitutions at conserved positions in the nuclear export signal (NES) of HIV-1 Rev. Biochem Biophys Res Commun 243:113–116
Acknowledgments
M. Cojocariu was supported by a graduate studentship from “La Fondation UQAM”. This work was supported by an operating Discovery grant from the National Sciences and Engineering Research Council of Canada to D. Archambault.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cojocariu, M., St-Louis, MC. & Archambault, D. Bovine immunodeficiency virus: identification of a long terminal repeat sequence with enhanced promoter activity. Arch Virol 154, 1163–1167 (2009). https://doi.org/10.1007/s00705-009-0411-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-009-0411-z